Printer Friendly

Does folinic acid ameliorates retinoic acid induced teratogenicity in chick embryo?

Byline: Ayesha Haque and Muhammad Yunus Khan

Abstract

Objective: To investigate the protective effect of folinic acid on the hatching ability and developmental defects in a retinoic acid-induced teratogenic model of chick embryo.

Methods: The experimental study was conducted at the Department of Anatomy, Regional Centre of the College of Physicians and Surgeons Pakistan, Islamabad, from February 2009 to February 2010. Chicken eggs were divided into two experimental groups and a control group. The first experimental group was injected with retinoic acid to induce a defective model, while the second experimental group was concomitantly injected folinic acid to observe its protective effects on retinoic acid-induced defects in the development and hatching process. Both groups were compared with the age-matched control group.

Results: A total of 90 fertilised eggs were divided into three groups. The experimental groups had significantly more delayed and assisted hatchings compared to the control group (pless than 0.05) but the difference between the experimental groups regarding the mode and day of hatching was insignificant (p>0.05).

Conclusion: Irrespective of the presence of folinic acid, prenatal retinoic acid exposure significantly altered the hatchability characteristics in the experimental groups compared to the control.

Keywords: Retinoic acid, Chick embryo, Folinic acid, Hatching. (JPMA 66: 302; 2016)

Introduction

Retinoic acid (RA), a metabolite of vitamin A, is a well- known teratogen. A distinctive constellation of defects labelled as RA embryopathy involves craniofacial, thymic and cranial structures.1

RA exerts its actions mainly through retinoid acid receptors (RARs) and rexinoid receptors (RXRs). These receptors bind to RA response elements (RAREs) in the regulatory regions of direct target genes. RA thus acts by gene transcription. Due to its potential to inhibit growth and promote differentiation, RA holds great therapeutic promise and its clinical role is expanding. In spite of the clinical benefits, there is a severe teratogenic risk associated with its use during pregnancy and despite continued warnings, the risk of foetal exposure to RA remains high.2,3 Animal studies along with recent epidemiological reports on human teratogenicity raise concerns about the potential for induction of defects in offspring of women of child-bearing age.

Recently a number of studies have demonstrated the protective role of folinic acid (FA), a metabolically active form of folic acid, against RA embryopathy. Memon and Pratten4 described its potential to prevent RA-induced cardiac defects in chick embryo, while Naseer et al.5 demonstrated its cardio-protective role against RA- induced teratogenicity in albino mice. Firat et al.6 concluded that prenatal administration of FA counters RA- induced defects in maxillofacial defective model in rats. Experimental work by Zhang et al.7 showed that FA supplementation can prevent RA-induced craniofacial abnormalities. Since there is considerable interest regarding the role of FA to counter the teratogenic effects of RA, the current study was planned to confirm the teratogenic potential of RA and determine the role of FA in countering teratogenesis imparted by RA in the form of visible defects and ability to hatch naturally.

Materials and Methods

The experimental study was carried out at the Department of Anatomy, Regional Centre, College of Physicians and Surgeons of Pakistan (CPSP), Islamabad, and comprised fertilised eggs belonging to Egyptian Fayoumi breed of Gallus domesticus which were obtained from the Poultry Research Institute, Punjab, Murree Road, Rawalpindi. The eggs were divided into 3 groups; two experimental and one control. The specimen was randomly selected for each group by using the random selection table. Further, 0.3ug of RA (Sigma) was dissolved in ethanol and subsequently dispensed in 0.5ml of saline. It was then injected in the experimental group A2 via yolk sac on day 0 of incubation.8 Experimental group B2 was injected with 5ug of FA in addition to RA via the same route and on the same day.9 Control group C2 was sham-injected with saline. The eggs were placed in the incubator and that day was considered day 1 of incubation.

Temperature in the incubator was maintained at 102F and relative humidity was kept between 70% and 80%. The eggs were turned periodically during the day.

The eggs were incubated until hatching or on day 22 of the incubation, whichever was earlier. If the chicks were unable to hatch by day 22, they were taken out of the shells manually.

The day and mode of hatching were noted. The mode was labelled as normal or assisted. Newly-hatched chicks were examined for gross abnormalities, an abnormal gait or behavioural abnormalities.

Fisher's exact test was employed to analyse any significant difference regarding the day and mode of hatching between the groups. Experimental groups A2 and B2 were compared in relation to developmental anomalies by applying chi-square test, and pless than 0.05 was considered statistically significant.

Results

There were 90 eggs in the study that were divided equally into three groups of 30(33.3%) each. In experimental group A2, the number of alive chicks was 24(80%) and in B2, it was 23(76.6%).

All the 30(100%) chicks belonging to the control group C2 cracked open the shell unassisted on day 21 of incubation. In group A2, 13(54.1%) of the alive chicks were able to crack open the egg shell unassisted on day 21, while 11(45.8%) had to be assisted after waiting till day 22.

Table-1: Comparison of the day and mode of hatching between the groups A2 and B2, A2andC2 and B2 and C2.

Group###Day and mode of hatching of alive chicks###Total alive chicks###P-value

###Day 21(natural)###Day 22 (assisted)

A2###13 (54.1%)###11(45.8%)###24

B2###19 (82.6%)###4 (17.39%)###23###0.059

Total###32 (68.0%)###15(31.91%)###47

A2###13 (54.1%)###11(45.8%)###24

C2###30 (100%)###0###30###less than0.0001

Total###43 (79.6%)###11(20.37%)###54

B2###19 (82.6%)###4 (17.39%)###23

C2###30 (100%)###0###30###0.030

Total###49 (92.4%)###4(7.54%)###53

Table-2: Comparison of the developmental anomalies between groups A2 and B2.

Variable###Group###Total alive chicks###p-value

###A2 (n=24)###B2 (n=23)

Apathy###11 (45.83%)###10 (43.47%)###21(44.68%)###0.871

Limb deformities###9(37.5%)###7(30.43%)###16(34.04%)###0.609

Abd. wall defects###11(45.83%)###9(39.1%)###20 (42.55%)###0.642

Thus, hatching was significantly delayed compared to the controls (pless than 0.000). In experimental group B2, 19(82.6%) of the alive chicks managed to hatch out of the shell without assistance on day 21, which was also significantly less than the controls (p=0.030). However, hatching was slightly improved compared to group A2 (p=0.591) (Table-1). Apathetic behaviour was assessed by diminished mobility and lack of interest in consuming food and water. Such behaviour was demonstrated by 11(45.83%) of the alive chicks in group A2 and 10(43.47%) in group B2. Contrastingly, C2 chicks were actively jumping and consuming food (Figure-1). The apathy demonstrated by group A2 was not significantly improved by co-administration of FA in group B2 (p=0.871).

Limb deformity, manifested by an inability to straighten the toes leading to limping on attempted walking, was demonstrated by 9(37.5%) chicks in group A2 and by 7(30.43%) in group B2 (p=0.609).

No gait abnormalities were shown by the controls.

In group A2, the anterior abdominal wall failed to close with failure of retraction of the yolk sac in 11(45.83%) chicks (Figure-2), while it was present in 9(39.1%) chicks of group B2 (p=0.642). All the controls showed fully formed anterior abdominal wall without any evisceration.

Discussion

Study results indicate that hatching was significantly delayed in the experimental groups, exposed prenatally to RA or RA with FA compared to the control group. Although there were slightly more unassisted hatchings on day 21 in B2 compared to A2, but the protection offered by FA was not enough to rescue the detrimental effects of RA.

The cause of delayed hatchings demonstrated by the experimental groups could have been the hypoactivity and motor dysfunction induced by central nervous system damage. This is in accordance with the findings of previous studies.10,11 Scientists have shown that prenatal RA exposure affects cortico-cerebellar connections and induces several structural abnormalities, including reduced cerebellar size and impaired foliation profile.12

The slight improvement in the ability to hatch naturally in B2 compared to A2 (p=0.591) could be because of the partial protective effect of FA. This can be explained by its role as 1-carbon donor for metabolism and methylation.13

RA acts by modulating the activity of transport systems for amino acid uptake, including methionine, which serves as methyl donor for deoxyribonucleic acid (DNA) synthesis.14,15 This decreased protein synthesis might have been prevented by supplemental FA, maintaining the optimal concentration of methyl donor for DNA synthesis.13

Regarding the behavioural abnormalities, the apathy demonstrated by the chicks belonging to the RA-injected group can be explained by the previously documented effect of RA on the brain in the form of decreased hypothalamic cells.16 This reduction in the hypothalamic cellular population can lead to increased depression- related behaviour in mice. This depression has been assessed by impaired locomotion by a number of studies.17-19 In this study, apathetic behaviour was not significantly improved by FA administration. This was probably because the damage induced by RA was irreversible.

Abnormal limb development is a well-known effect of exogenous RA, and the results of our study were commensurate with previous scientific work.

Although the difference was not statistically significant, but limb deformities decreased from 37.5% in A2 to 30.43% in B2, indicating minimal protection imparted by FA. Many scientists have shown the capability of FA to prevent congenital anomalies. RA can interfere with DNA synthesis leading to apoptosis, while FA could interfere with apoptosis and preserve chondrocyte proliferation.

Our study also showed a predominant failure of retraction of yolk sac into the abdominal wall. Normally yolk sac starts retracting at 19th day and completely retracts on day 20 of incubation.24 Researchers have shown that abdominal wall defects, particularly omphalocele, are associated with prenatal RA administration in animals.

DNA mutations are implicated as the cause.26 The incidence of failed yolk sac retraction was seen in the FA- injected group as well. Thus FA administration could only partially rescue the developmental defects induced by RA (Figure-3).

Conclusion

RA significantly delayed hatching and induced developmental defects, irrespective of the presence or absence of FA. Chicks exposed to RA had considerably more assisted hatchings and exhibited apathetic behaviour, limb deformities and abdominal wall defects. Further studies are essential to ensure better understanding of the extent of protection offered by FA against teratogenesis.

References

1. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313: 837-41.

2. Honein MA, Paulozzi LJ, Erickson JD. Continued occurrence of Accutane-exposed pregnancies. Teratology 2001; 64: 142-7.

3. Chan A, Hanna M, Abbott M, Keane RJ. Oral retinoids and pregnancy. Med J Aust 1996; 165: 164-7.

4. Memon S, Pratten MK. The potential of folic acid to prevent retinoic acid induced cardiac defects: an evaluation in chick cardiac micromass culture. J Anat 2008; 212: 84-5.

5. Naseer U, Tahir M, Lone KP, Munir B, Sami W. Effect of folic acid on vitamin A induced cardiac teratogenicity in albino mice. Pak J Zool 2011; 43: 461-7.

6. Firat D, Kuntsal L, Sirin Y. Protective effects of prenatal administration of folic acid on retinoic acid-induced cellular damages of Meckel's cartilage in rats. Tohoku J Exp Med 2005; 205: 27-36.

7. Zhang Z, Xu Y, Li L, Han J, Zheng L, Liu P, et al. Prevention of retinoic acid-induced early craniofacial abnormalities by folinic acid and expression of endothelin-1/dHAND in the branchial arches in mouse. Br J Nutr 2006; 96: 418-25.

8. Jelinek R, Kistler A. Effect of retinoic acid upon the chick embryonic morphogenetic systems.I. The embryotoxicity dose range. Teratology 1981; 23: 191-5.

9. Li Y, Li Z, Chen X, Qi P. [Homocysteine-induced neural tube defects in chick embryos and protection of folic acid]. Wei Sheng Yan Jiu 1998; 27: 372-6.

10. Coluccia A, Borracci P, Belfiore D, Renna G, Carratu MR. Late embryonic exposure to all-trans retinoic acid induces a pattern of motor deficits unrelated to the developmental stage. Neurotoxicology 2009; 30: 1120-6

11. Kamran K, Khan MY, Minhas L. Teratogenic effects of ethanol vapour exposure on chick embryos. J Pak Med Assoc 2011; 61: 328-31.

12. Coluccia A, Belfiore D, Bizzoca A, Borracci P, Trerotoli P, Gennarini G, et al. Gestational all-trans retinoic acid treatment in the rat: neurofunctional changes and cerebellar phenotype. Neurotoxicol Teratol 2008; 30: 395-403.

13. Guay F, Matte JJ, Girard CL, Palin MF, Giquere A, Laforest JP, et al. Effect of folic acid and glycine supplementation on embryo development and folate metabolism during early pregnancy in pigs. J Anim Sci 2002; 80: 2134-43.

14. Koziorowska J, Paczek K, Tautt J. Influence of retinoic acid on protein synthesis and transport of L-methionine in cultured L cells. Exp Cell Res 1984; 150: 97-103.

15. Krupsky M, Fine A, Berk JL, Goldstein RH. The effect of retinoic acid on amino acid uptake and protein synthesis by lung fibroblasts. J Biol Chem 1993; 268: 23283-8.

16. Griffin JN, Pinali D, Olds K, Lu N, Appleby L, Doan L, et al. 13-Cis- retinoic acid decreases hypothalamic cell number in vitro. Neurosci Res 2010; 68: 185-90.

17. O'Reilly KC, Shumake J, Gonzalez-Lima F, Lane MA, Bailey SJ. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychophamacology 2006; 31:1919-27.

18. O'Reilly K, Bailey SJ, Lane MA. Retinoid-mediated regulation of mood: possible cellular mechanisms. Exp Biol Med 2008; 233: 251-8.

19. Hazen PG, Carney JF, Walker AE, Stewart JJ. Depression-a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol 1983; 9: 278-9.

20. Lee GS, Kochhar DM, Collins MD. Retinoid-induced limb malformations. Curr Pharm Des 2004; 10: 2657-99.

21. Cash DE, Bock CB, Schuqhart K, Linney E, Underhill TM. Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: a modulator of chondrogenesis. J Cell Biol 1997; 136: 445-57.

22. Underhill TM, Weston AD. Retinoids and their receptors in skeletal development. Microsc Res Tech 1998; 43: 137-55.

23. 1ian CJ, Cool JC, Scherer MA, Fan C, Foster BK. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells. J Cell Physiol 2008; 214: 777-85.

24. Shrack JE, Darre MJ. Helpful hints for teachers on incubation and embryology of the chick. [Online] [Cited 2007 Jan 25]. Available from: URL: http://www.web.uconn.edu/poultry/4poultry/help_inset.html

25. Colakoglu N, Kukner A. Teratogenicity of retinoic acid and its effects on TGF-beta2 expression in the developing cerebral cortex of the rat. J Mol Histol 2004; 35: 823-7.

26. Van Drop DR, Malleis JM, Sullivan BP, Klein MD. Teratogens inducing congenital abdominal wall defects in animal models. Pediatr Surg Int 2010; 26: 127-39.
COPYRIGHT 2016 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Journal of Pakistan Medical Association
Date:Mar 31, 2016
Words:2709
Previous Article:Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy.
Next Article:The role of NT-proBNP and Apelin in the assessment of right ventricular dysfunction in acute pulmonary embolism.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters